Although there is an association between Helicobacter Pylori (HP) infection and blood group, the effect of blood groups on HP eradication is not yet known. Our aim in the study was to investigate the relationship between blood group and other risk factors with HP eradication after HP eradication therapy. 104 patients who underwent gastrointestinal system endoscopy and received gastric tissue biopsies were enrolled in the study at our hospital between June 2017-December 2018. Demographic and histopathological data of all patients were documented. HP eradication was performed by giving Amoxicillin and Clarithromycin and Pantoprazole treatment to all patients. Patients were divided into two groups according to HP eradication. The relationship between HP eradication rate and blood groups and risk factors was analyzed. A total of 104 HP positivity was included in the study. The mean age of the patients was 47.7±14.6 years old. Fifty -two (50%) patients were women, the body mass index (BMI) was 27.6±4.7 (range:17.7 -42.1). The distribution of blood groups were 49(47.1%) A, 13(12.5%) B, 9(8.7%) O, 33(31.7%) AB. HP eradication occurred in 70 (67.3%) patients after HP treatment. HP eradication rate was significantly higher in women, but there was no significant relation between HP eradication and age, BMI or blood groups. In conclusion, while there was a significant relationship between gender and HP eradication, no significant relationship was observed between ABO blood groups and HP eradication
___
1. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-789.
2. Lu B, Chen MT, Fan YH, Liu Y, Meng LN. Effects of Helicobacter pylori eradication on atrophic gastritis and intestinal metaplasia: a 3 year follow-up study. World J Gastroenterol 2005; 11: 6518-6520.
3. AginM, Kayar Y. The prevalence of Helicobacter Pylori and related conditions in Van province and its region. Ann Med. Res 2019; 26: 2568-2577.
4. Ekinci O, Kara O, Demircioglu S, et al. Evaluation of transfusion transmitted infections and distribution of ABO and Rh blood groups in donors in Eastern Turkey. Ann Med Res 2019; 26: 2088-2092.
5. Yokota N, Amenomori M, Kitagawa K, et al. Clinical background factors affecting outcome s of Helicobacter pylori eradication therapy I Primary care. J Gen Fam Med 2019; 20: 139- 145.
6. Kayar Y, Pamukçu Ö, Eroğlu H, Kalkan Erol K, Ilhan A, Kocaman O. Relationship between Helicobacter pylori Infections in Diabetic Patients and Inflammations, Metabolic Syndrome, and Complications. Int J Chronic Dis 2015; 2015: 290128.
7. Hu KC, Wu MS, Chu CH, et al. Hyperglycemia combined Helicobacter pylori infection increases risk of synchronous colorectal adenoma and carotid artery plaque. Onco target 2017; 8: 108655-108664.
8. Naja F, Kreiger N, and Sullivan T. H. pylori infection in Ontario: Prevalenc eand risk factors. Can J Gastroenterol 2007; 21: 501- 506.
9. Agin M, Kayar Y, Dertli R. The relationship between mean platelet volume and platelet levels of children with Helicobacter pylori and gastritis. Prz Gastroenterol 2019; 14: 198-201.
10. Seyda T, Derya C, Fusun A, Meliha K. The relationship of H. pylori positivity with age, sex, and ABO / Rhesus blood groups in patients with gastrointestinal complaints in Turkey. Helicobacter 2007; 12: 244-250.
11. Suzuki T, Matsuo K, Ito H, et al. Smoking increases the treatment failure for Helicobacter pylori eradication. Am J Med 2006; 119: 217-224.
12. Shakya Shrestha S, Bhandari M, Thapa SR, et al. Medication adherence pattern and factors affecting adherence in Helicobacter pylori eradication therapyKathmandu Univ Med J 2016; 14: 58-64.
13. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-1181.
14. Shimoyama T. Stool antigen tests for the management of Helicobacter pylori infection. World J Gastroenterol 2013; 19: 8188.
15. Vaira D, Malfertheiner P, Megraud F, et al. Diagnosis of Helicobacter pylori infection with a new non-in vasive antigen-based assay. The Lancet 1999; 354: 30-33.
16. Baysal B, Şentürk H, Masri O, et al. Effect of pantoprazole and Helicobacter pylori therapy on uninvestigated dyspeptic patients. Turk J Gastroenterol 2015; 26: 6-14.
17. Gebeyehu E, Nigatu D, Engidawork E. Helicobacter pylori eradication rate of standar d triple therapy and factors affecting eradicati onrate at Bahir Dar city administration, North west Ethiopia: A prospective follow up study. PLoS One 2019; 14: 0217645.
18. Graham DY, Lew GM, Malaty HM, et al. Factors influencing the eradication of Helicob acter pylori with triple therapy. Gastroenterology 1992; 102: 493-496.
19. Mamori S, Higashida A, Kawara F, et al. Age dependent eradication of Helicobacter pylori in Japanese patients. World J Gastroenterol 2010; 16: 4176-4179.
20. Queiroz DM, Dani R, Silva LD, et al. Factors associated with treatment failure of Helicobacter pylori infection in a developingcountry. J Clin Gastroenterol 2002; 35: 315- 320.
21. Kabakambira JD, Hategeka C, Page C, et al. Efficacy of Helicobacter pylori eradication regimens in Rwanda: a randomized controlled trial. BMC Gastroenterology 2018; 18: 134.
22. Reid ME. Bird GW. Associations between human red cell blood group antigens and disease. Transfus Med Rev 1990; 4: 47-55.
23. Aspholm-Hurtig, M, Dailide G, Lahmann M, et al. Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin. Science 2004; 305: 519-522.
24. Hasbal NB, Kahramanca Ş, Anuk T. The Relationship between Helicobacter Pylori Infection and Sex, Blood groups and Rhesus Factor at the patients with Chronic Gastritis. IKSST Dergisi 2016; 8: 93-96.
25. Mattos DE, Cintra JR, Brandão de Mattos CC, et al. ABO blood groups and Helicobacter pylori cagA infection: evidence of an association. J Venom Anim Toxins incl Trop Dis 2010; 16: 87-95.
26. Alkout AM, Blackwell CC, Weir DM. Increased inflammatory responses of persons of blood group O to Helicobacter pylori. J Infect Dis 2000; 181: 1364-1369.